VP Global Asset Lead

The VP Global Asset Lead for Corabotase Therapeutics serves as the single global enterprise owner, accountable for shaping and delivering the integrated asset strategy across migraine, spasticity, cervical dystonia, and future therapeutic opportunities. This role drives the asset from proof-of-concept through pivotal development, regulatory strategy, access readiness, and global launch preparation. The position requires building the investment case, defining strategic playbooks, and ensuring the asset is assessed within the broader Neuroscience franchise alongside Dysport and other portfolio opportunities.